Trazodone Cost in South Dakota 2026

What Trazodone Actually Costs in South Dakota Right Now

Generic trazodone is among the most affordable prescription medications available in South Dakota in 2026. The average cash price across retail pharmacies in the state runs about $10 per month for a standard 30-tablet supply. The manufacturer list price sits closer to $40 per month, but essentially no cash-pay patient pays that figure.

Trazodone received FDA approval as an antidepressant in 1981 and has been off-patent for decades, which is why generics dominate the market and drive prices down sharply. The FDA prescribing information for trazodone confirms it as a serotonin antagonist and reuptake inhibitor (SARI) indicated for major depressive disorder.

Retail Chain Prices Across South Dakota

Prices vary by pharmacy and by which discount program you use. At Walmart, Walgreens, and Hy-Vee locations throughout Sioux Falls, Rapid City, and Aberdeen, cash prices for 30 tablets of trazodone 50 mg range from $9 to $15 without any coupon. Adding a GoodRx or RxSaver code typically brings the price to $9 to $12 at the same counters.

Independent pharmacies in rural South Dakota sometimes price trazodone slightly higher at $12 to $18 per month, though many participate in the same discount card networks. Calling ahead to compare is worth a few minutes. A 90-day supply often costs less per tablet than a 30-day fill.

Price by Strength

Higher-strength tablets are not always more expensive on a per-milligram basis. Trazodone 100 mg tablets typically cost $10 to $16 per month for 30 tablets, while 150 mg extended-release tablets (Oleptro generic) can run $15 to $25 per month. The immediate-release 50 mg and 100 mg formulations consistently hold the lowest price points across South Dakota dispensaries.

A 2005 clinical study by Mendelson published in the Journal of Clinical Psychiatry confirmed trazodone's effectiveness at doses of 50 to 150 mg for sleep maintenance, which aligns with the lower-strength tablets that carry the lowest price tags in South Dakota.

South Dakota Medicaid and Trazodone Coverage

South Dakota Medicaid does not currently list trazodone on its preferred drug list for most beneficiaries. This is a meaningful gap. Roughly 130,000 South Dakotans are enrolled in Medicaid, and depression affects an estimated 17.3 million U.S. Adults annually according to NIMH data via the NIH. Patients who rely on Medicaid for other prescriptions may be surprised to find trazodone requires an out-of-pocket payment.

Prior Authorization Pathways

Some Medicaid managed care plans operating in South Dakota may approve trazodone through a prior authorization (PA) process, particularly for patients who have failed formulary antidepressants such as sertraline or fluoxetine. The PA pathway is not guaranteed and varies by managed care organization. Your prescribing clinician can submit a PA request citing a documented treatment failure.

The South Dakota Department of Social Services publishes the current preferred drug list and PA criteria online. Reviewing that list before your appointment saves time.

Medicaid vs. Cash Pay

For the majority of South Dakota Medicaid patients who cannot get PA approval, cash pay at $10 per month is often the practical path. At that price point, the financial burden is lower than many patients expect. If your income qualifies for Medicaid, it may also qualify you for patient assistance programs from manufacturers, which can bring cost to zero.

How Discount Cards and Savings Programs Work in South Dakota

Discount cards are not insurance. They are negotiated pricing agreements between pharmacy benefit managers and retail pharmacies. In South Dakota, the most widely accepted programs include GoodRx, RxSaver, NeedyMeds, and the Partnership for Prescription Assistance.

GoodRx in South Dakota

GoodRx consistently shows trazodone 50 mg (30 tablets) for $9 to $12 at Sioux Falls and Rapid City locations. The card is free, requires no enrollment, and can be used by anyone regardless of insurance status. The GoodRx pricing mechanism is documented by the FDA's drug pricing transparency resources as a third-party adjudication model.

You cannot use a GoodRx discount at the same time as insurance. Choose whichever is lower on any given fill. For trazodone, cash plus GoodRx is almost always cheaper than running it through insurance with a copay.

NeedyMeds and Patient Assistance

The NeedyMeds database at NIH-affiliated resources identifies manufacturer patient assistance programs (PAPs) for lower-income patients. Trazodone's generic manufacturers do not typically run branded PAPs, but the low cash price ($9 to $10/month) makes this less of a practical concern than for specialty drugs.

The Health Resources and Services Administration (HRSA) 340B program covers certain federally qualified health centers in South Dakota, including community health centers in Sioux Falls and Rapid City. Patients seen at 340B-covered sites may access trazodone at sharply reduced cost, sometimes under $5 per month.

Manufacturer vs. Third-Party Cards

Because trazodone is generic, no single manufacturer runs a copay card the way branded drugs do. Third-party aggregators like GoodRx, SingleCare, and ScriptSave WellRx each pull from their own network contracts. Checking two or three before filling costs nothing and can save $3 to $8 per fill.

Compounded Trazodone in South Dakota: Legality and Cost

Compounded trazodone from a licensed 503A pharmacy is legal in South Dakota. This matters for patients who need non-standard doses, alternative delivery forms (such as liquid suspension for patients with swallowing difficulties), or who are enrolled in telehealth programs that include compounding as part of their care package.

What 503A Means

A 503A pharmacy is a state-licensed compounding pharmacy that prepares medications for individual patients based on a valid prescription. The FDA's guidance on 503A compounding pharmacies distinguishes these from 503B outsourcing facilities, which compound in bulk without patient-specific prescriptions. South Dakota follows federal 503A standards and has its own pharmacy board oversight through the South Dakota State Board of Pharmacy.

Compounded trazodone does not require commercial-grade packaging, which is one reason the cost can drop substantially. In some telehealth-integrated programs, compounded trazodone carries a $0 out-of-pocket cost when bundled with a subscription-based care plan.

When Compounding Makes Sense

Compounding is appropriate when a commercially available dose strength does not meet a patient's clinical need. For example, a patient requiring 25 mg (half the lowest commercial tablet) for sleep initiation might benefit from a compounded 25 mg capsule or liquid rather than splitting tablets. A systematic review in the British Medical Journal on off-label prescribing found that off-label use of psychotropics for sleep is common and generally supported by clinical evidence when dose titration is individualized.

Compounding is not a workaround for formulary exclusions without clinical justification. South Dakota prescribers are expected to document a legitimate clinical reason for a compounded formulation rather than a commercially available one.

The HealthRX Trazodone Access Framework for South Dakota categorizes patients into three tiers based on access pathway:

Tier 1 (Cash pay, no insurance): Fill generic trazodone at any retail pharmacy using GoodRx or RxSaver. Expected cost: $9 to $12/month.

Tier 2 (Medicaid, PA denied): Use cash pay or apply to a 340B-covered health center in Sioux Falls or Rapid City for sub-$5 fills. Request PA through your managed care plan if you have failed a preferred antidepressant.

Tier 3 (Telehealth + compounding): Enroll with a licensed telehealth provider operating in South Dakota. If a 503A compounding partner is included, out-of-pocket cost may be $0 for the medication itself, with a separate monthly program fee.

Telehealth Prescribing of Trazodone in South Dakota

Telehealth prescribing of trazodone is fully legal in South Dakota as of 2026. South Dakota follows the Ryan Haight Act requirements, which mandate at least one real-time audio/video evaluation before a controlled substance is prescribed. Trazodone is not a controlled substance, so the prescribing threshold is lower: a synchronous telehealth visit (video or phone with video capability) satisfies South Dakota licensure requirements.

South Dakota Telehealth Rules

South Dakota law under SDCL Chapter 36-4 governs telehealth for licensed physicians and mid-level practitioners. Prescribing trazodone via telehealth requires the clinician to hold a valid South Dakota license or qualify under an interstate compact. The American Telemedicine Association clinical guidelines recommend that asynchronous-only encounters (questionnaire-based, no live visit) not be used for initial psychiatric medication prescribing, a standard most reputable telehealth platforms follow.

What a Telehealth Visit Covers

A standard telehealth mental health visit in South Dakota runs $75 to $150 out of pocket if not covered by insurance. Many commercial plans, including Wellmark Blue Cross Blue Shield and Sanford Health Plan, cover telehealth mental health visits at parity with in-person visits under the federal Mental Health Parity and Addiction Equity Act. The MHPAEA is codified and reviewed by CMS.

After the visit, the trazodone prescription can be sent electronically to any South Dakota pharmacy, or to a 503A compounding pharmacy if a compounded formulation is clinically appropriate.

Platforms Operating in South Dakota

Several national telehealth platforms list South Dakota as a covered state for psychiatric and sleep medicine prescribing as of mid-2025. These include platforms that specialize in sleep disorders, anxiety, and depression. Response times for new patient evaluations range from same-day to 72 hours in most cases. Rural South Dakota residents in areas without a local psychiatrist stand to benefit most from this access model, given that rural mental health access gaps are documented by SAMHSA.

Insurance Coverage for Trazodone in South Dakota

Most private insurance plans in South Dakota cover generic trazodone on Tier 1 or Tier 2 of their formulary, meaning copays of $0 to $15 per month. Sanford Health Plan, Wellmark Blue Cross Blue Shield, and Avera Health Plans all include generic trazodone on standard formularies based on publicly available 2025 drug lists.

Tier Placement and Copays

Tier 1 generic copays at major South Dakota insurers typically run $0 to $5 for a 30-day supply. Tier 2 placement (preferred generic) typically means $5 to $15 per month. Because trazodone's cash price is already $10, insurance only provides meaningful savings if your copay is under $10. Check your plan's specific formulary at HealthCare.gov's formulary lookup or call the member services number on your card.

A Cochrane systematic review on antidepressant formulary access found that formulary restrictions on antidepressants are associated with delays in treatment initiation, a pattern relevant to South Dakota Medicaid's current non-coverage of trazodone.

Medicare Part D in South Dakota

Medicare Part D plans available in South Dakota generally include generic trazodone on formulary. The 2026 Medicare redesign under the Inflation Reduction Act caps out-of-pocket drug costs and places generic antidepressants in low-cost tiers. CMS published the 2026 Part D framework confirming these parameters. Most South Dakota Part D enrollees pay $0 to $5 per month for trazodone.

Employer-Sponsored Plans

South Dakota's largest employers, including state government, Sanford Health, Avera McKennan, and Ellsworth Air Force Base, provide group health plans that universally include generic antidepressants. Trazodone appears on essentially all group formularies as a low-cost generic. Your HR benefits portal or the pharmacy benefits manager (Express Scripts, CVS Caremark, OptumRx) can confirm your specific copay tier.

Clinical Background: Why Trazodone Is Prescribed

Trazodone is FDA-approved for major depressive disorder. Off-label, clinicians commonly prescribe it at lower doses (25 to 100 mg) for insomnia, given its sedating properties at sub-therapeutic antidepressant doses. The Mendelson 2005 study in the Journal of Clinical Psychiatry (PMID 15842181) demonstrated that trazodone 50 to 150 mg significantly improved sleep latency and maintenance versus placebo in adults with primary insomnia, with a favorable side-effect profile compared to benzodiazepines.

Mechanism of Action

Trazodone blocks 5-HT2A receptors and inhibits serotonin reuptake. At low doses, H1 (histamine) antagonism dominates, producing sedation. At antidepressant doses (150 to 400 mg/day), serotonin reuptake inhibition becomes the primary mechanism. The FDA label specifies that therapeutic antidepressant response may take two to four weeks to emerge.

This dual dose-dependent mechanism is why trazodone occupies an unusual niche: one drug serving meaningfully different clinical purposes depending on dose. A National Institutes of Health review of trazodone pharmacology details this dose-response relationship.

Safety Considerations Relevant to Access Decisions

Trazodone carries a black-box warning for suicidality in patients under 25 years of age, consistent with all antidepressants. Priapism, while rare, is the adverse effect most specific to trazodone. The FDA MedWatch database contains post-marketing reports. These safety considerations are why a valid prescription from a licensed clinician is required, and why telehealth platforms must conduct a real-time clinical evaluation before prescribing.

Orthostatic hypotension is clinically meaningful in older adults, who represent a substantial share of trazodone users in South Dakota given the state's older-than-average population. The CDC's data on older adult falls is relevant context when prescribers weigh trazodone's sedating effects in patients over 65.

Dosing for Sleep vs. Depression

For insomnia: 25 to 100 mg taken 30 minutes before bed is the typical starting range. For major depressive disorder: 150 mg/day in divided doses, titrating to a maximum of 400 mg/day for outpatients. These dose ranges are derived from the FDA-approved labeling and supported by the American Academy of Sleep Medicine clinical practice guidelines.

A JAMA Internal Medicine analysis of prescription sleep aid utilization found that trazodone ranked among the most frequently prescribed medications for sleep in primary care settings, despite lacking an FDA sleep indication, reflecting widespread clinical acceptance of the off-label use.

Comparing Trazodone to Alternatives on Cost

South Dakota patients sometimes ask how trazodone compares to other options. Generic sertraline costs $10 to $15 per month cash in South Dakota and is Medicaid-covered, making it preferable on the formulary access dimension for depressed patients. Generic zolpidem runs $10 to $20 per month but is a Schedule IV controlled substance with additional prescribing restrictions.

Eszopiclone and zaleplon carry similar pricing and controlled-substance classifications. Mirtazapine, another sedating antidepressant used off-label for sleep, costs $10 to $18 per month and appears on some South Dakota Medicaid preferred lists. The NIH National Library of Medicine's DailyMed database is the authoritative source for current prescribing information across all these agents.

Trazodone's non-controlled status is a meaningful practical advantage: no DEA prescribing limits, no state prescription drug monitoring program (PDMP) mandate in South Dakota for non-controlled substances, and no federally mandated quantity limits for telehealth prescribing.